BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 31662858)

  • 1. The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches.
    Ungaro F; Massimino L; D'Alessio S; Danese S
    United European Gastroenterol J; 2019 Oct; 7(8):999-1007. PubMed ID: 31662858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.
    Ungaro F; Massimino L; Furfaro F; Rimoldi V; Peyrin-Biroulet L; D'Alessio S; Danese S
    Gut Microbes; 2019; 10(2):149-158. PubMed ID: 30252582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: the human intestinal virome in health and disease.
    Carding SR; Davis N; Hoyles L
    Aliment Pharmacol Ther; 2017 Nov; 46(9):800-815. PubMed ID: 28869283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Virome and Disease: High-Throughput Sequencing for Virus Discovery, Identification of Phage-Bacteria Dysbiosis and Development of Therapeutic Approaches with Emphasis on the Human Gut.
    Santiago-Rodriguez TM; Hollister EB
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut virome in inflammatory bowel diseases.
    Liang G; Cobián-Güemes AG; Albenberg L; Bushman F
    Curr Opin Virol; 2021 Dec; 51():190-198. PubMed ID: 34763180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut virome in inflammatory bowel disease and beyond.
    Tun HM; Peng Y; Massimino L; Sin ZY; Parigi TL; Facoetti A; Rahman S; Danese S; Ungaro F
    Gut; 2024 Jan; 73(2):350-360. PubMed ID: 37949638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VirusSeeker, a computational pipeline for virus discovery and virome composition analysis.
    Zhao G; Wu G; Lim ES; Droit L; Krishnamurthy S; Barouch DH; Virgin HW; Wang D
    Virology; 2017 Mar; 503():21-30. PubMed ID: 28110145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease.
    Clooney AG; Sutton TDS; Shkoporov AN; Holohan RK; Daly KM; O'Regan O; Ryan FJ; Draper LA; Plevy SE; Ross RP; Hill C
    Cell Host Microbe; 2019 Dec; 26(6):764-778.e5. PubMed ID: 31757768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases.
    Armstrong H; Alipour M; Valcheva R; Bording-Jorgensen M; Jovel J; Zaidi D; Shah P; Lou Y; Ebeling C; Mason AL; Lafleur D; Jerasi J; Wong GK; Madsen K; Carroll MW; Huynh HQ; Dieleman LA; Wine E
    Microbiome; 2019 Jan; 7(1):1. PubMed ID: 30606251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD.
    Matijašić M; Meštrović T; Paljetak HČ; Perić M; Barešić A; Verbanac D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of metagenomics in the human gut microbiome.
    Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
    World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ViromeScan: a new tool for metagenomic viral community profiling.
    Rampelli S; Soverini M; Turroni S; Quercia S; Biagi E; Brigidi P; Candela M
    BMC Genomics; 2016 Mar; 17():165. PubMed ID: 26932765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome analysis, the immune response and transplantation in the era of next generation sequencing.
    Kanangat S; Skaljic I
    Hum Immunol; 2021 Nov; 82(11):883-901. PubMed ID: 34364710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing the human microbiome: a "how to" guide for physicians.
    Tyler AD; Smith MI; Silverberg MS
    Am J Gastroenterol; 2014 Jul; 109(7):983-93. PubMed ID: 24751579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities.
    Norman JM; Handley SA; Virgin HW
    Gastroenterology; 2014 May; 146(6):1459-69. PubMed ID: 24508599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral metagenomic analysis of fecal samples reveals an enteric virome signature in irritable bowel syndrome.
    Ansari MH; Ebrahimi M; Fattahi MR; Gardner MG; Safarpour AR; Faghihi MA; Lankarani KB
    BMC Microbiol; 2020 May; 20(1):123. PubMed ID: 32429898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?
    Lacroix V; Cassard A; Mas E; Barreau F
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.